Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Phase 1 Study of CART-Ddbcma, a CAR-T Therapy Utilizing a Novel Synthetic Binding Domain for the Treatment of Subjects with Relapsed and Refractory Multiple Myeloma

Matthew J Frigault, MD MSc, Michael R. Bishop, MD, Elizabeth K. O'Donnell, MD, Noopur S. Raje, MD, Allegra Mondillo, Daniella Cook, Heather Daley, Carissa Mangus, David W LeFleur, Janine M Buonato, Justin P Edwards, Laura K Richman, DVM, PhD, Maria T Polianova, PhD, Maria Sabatino, MD, Scott Currence, Angela Shen, MD, Travis Quigley, MS, Marcela V. Maus, MD PhD

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-142931

Published: 2020

Journal Articles

Idecabtagene Vicleucel (ide-cel, bb2121), a BCMA-Directed CAR T Cell Therapy, in Patients with Relapsed and Refractory Multiple Myeloma: Updated Results from Phase 1 CRB-401 Study

Yi Lin, MD PhD, Noopur S. Raje, MD, Jesus G. Berdeja, MD, David S. Siegel, MD PhD, Sundar Jagannath, MD, Deepu Madduri, MD, Michaela Liedtke, MD, Jacalyn Rosenblatt, MD, Marcela V. Maus, MD PhD, Monica Massaro, MPH, Fabio Petrocca, MD, Andrea Caia, MS, Zhihong Yang, PhD, Timothy B. Campbell, MD PhD, Kristen Hege, MD, Nikhil C. Munshi, MD, James N. Kochenderfer, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-134324

Published: 2020

Journal Articles

Use of CD70 Targeted Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Acute Myeloid Leukemia (AML)

Mark Leick, MD, Irene Scarfò, PhD, Bryan D. Choi, MD PhD, Rebecca Larson, BS, Amanda A Bouffard, Ana Castano, MD, Maria L. Cabral, BS, Andrea Schmidts, MD, Matthew J. Frigault, MD, Marcela V. Maus, MD PhD

Blood (2019) 134 (Supplement_1): 4443.

https://doi.org/10.1182/blood-2019-127154

Published: 2019

Journal Articles

Application of a Standardized Flow Cytometry Panel for Defining and Monitoring the Immunophenotype of CAR-T Cells

Irene Scarfò, PhD, Kathleen Gallagher, Marcela V. Maus, MD PhD, Rebecca Larson, BS, Maegan Sheehan, BS, Gabrielle Brini, MSc, Scott Bornheimer, Mary Beth Hanley, Matthew Frigault, MD MSc, Mark Leick, MD, Alena Chekmasova, PhD

Blood (2019) 134 (Supplement_1): 5626.

https://doi.org/10.1182/blood-2019-128745

Published: 2019

Journal Articles

Exploiting the Zinc Finger Degrome Targeted By Lenalidomide to Engineer Reversible Off-Switch Degradable Chimeric Antigen Receptors

Max Jan, MD PhD, Ana Castano, MD, Amanda Walker, BA, Andrew A Guirguis, MD PhD, Jessica A Gasser, PhD, Amanda A Bouffard, Mikolaj Slabicki, PhD, Alexander Tepper, Daniel E Grinshpun, Taeyoon Kyung, PhD, Quinlan Sievers, MD PhD, Michael E Birnbaum, PhD, Marcela V Maus, MD PhD, Benjamin L. Ebert, MD PhD

Blood (2019) 134 (Supplement_1): 866.

https://doi.org/10.1182/blood-2019-124210

Published: 2019

Journal Articles

Engineering an Optimized Trimeric APRIL-Based CAR to Broaden Targetability of Multiple Myeloma

Andrea Schmidts, MD, Maria Ormhoj, MS, Allison O. Taylor, MS, Selena J. Lorrey, BA, Irene Scarfò, PhD, Matthew J. Frigault, MD, Bryan D. Choi, MD PhD, Marcela V. Maus, MD PhD

Blood (2018) 132 (Supplement 1): 2059.

https://doi.org/10.1182/blood-2018-99-119633

Published: 2018

Journal Articles

Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics

Nandini Mondal, PhD, Mariana Silva, PhD, Ana Castano, MD, Marcela V. Maus, MD PhD, Robert Sackstein, MD PhD

Blood (2018) 132 (Supplement 1): 2056.

https://doi.org/10.1182/blood-2018-99-118675

Published: 2018

Journal Articles

Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity

Blood (2018) 132 (Supplement 1): 92.

https://doi.org/10.1182/blood-2018-99-117199

Published: 2018

Journal Articles

Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Blood (2018) 132 (Supplement 1): 896.

https://doi.org/10.1182/blood-2018-99-111356

Published: 2018

Journal Articles

Expression of B Cell Maturation Antigen (BCMA) and Transmembrane Activator and Caml Interactor (TACI) Are Correlated and Can be Targeted at Multiple Points during the Course of Multiple Myeloma

Allison O. Taylor, Matthew J. Frigault, MD, Felipe Bedoya, PhD, Michelle E. DeLelys, Alexandra J. Shay, Rachel T. Nicholson, Noopur Raje, MD, Fredric I. Preffer, PhD, Timothy A. Graubert, MD, Marcela V. Maus, MD PhD

Blood (2017) 130 (Supplement 1): 5363.

https://doi.org/10.1182/blood.V130.Suppl_1.5363.5363

Published: 2017

Journal Articles

Durable Clinical Responses in Heavily Pretreated Patients with Relapsed/Refractory Multiple Myeloma: Updated Results from a Multicenter Study of bb2121 Anti-Bcma CAR T Cell Therapy

Jesus G. Berdeja, MD, Yi Lin, MD PhD, Noopur Raje, MD, Nikhil Munshi, MD, David Siegel, MD PhD, Michaela Liedtke, MD, Sundar Jagannath, MD, Marcela V. Maus, MD PhD, Ashley Turka, Lyh Ping Lam, PharmD, RPh, Kristen Hege, MD, Richard A. Morgan, PhD, Michael Travis Quigley, James N. Kochenderfer, MD

Blood (2017) 130 (Supplement 1): 740.

https://doi.org/10.1182/blood.V130.Suppl_1.740.740

Published: 2017

Journal Articles

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CTL019) in Conjunction with Salvage Autologous Stem Cell Transplantation for Advanced Multiple Myeloma

Blood (2016) 128 (22): 974.

https://doi.org/10.1182/blood.V128.22.974.974

Published: 2016

Journal Articles

A Novel Phase-Change Hydrogel Substrate for T Cell Activation Promotes Increased Expansion of CD8+ Cells Expressing Central Memory and Naive Phenotype Markers

Nithya J Jesuraj, PhD, Julie M Cole, BA, BS, Felipe Bedoya, PhD, Steven B Wells, BS, Guokui Qin, PhD, Sean Kevlahan, PhD, Marcela V. Maus, MD PhD, Andrew J Ball, PhD

Blood (2016) 128 (22): 3368.

https://doi.org/10.1182/blood.V128.22.3368.3368

Published: 2016

Journal Articles

Artificial Antigen Presenting Cells Expand NY-ESO-1 Antigen-Specific CD8+ T Cells From Patients with Melanoma

Marcela V. Maus, MD, PhD, Isabelle Riviere, PhD, Oriana Borquez-Ojeda, Xiuyan Wang, PhD, Jianda Yuan, MD, Taha Merghoub, PhD, Jason Plotkin, Richard J. O’Reilly, MD, Jedd D Wolchok, MD, PhD, Michel Sadelain, MD, PhD

Blood (2011) 118 (21): 4309.

https://doi.org/10.1182/blood.V118.21.4309.4309

Published: 2011

Journal Articles

Quantifying Capsid Peptide:MHC I Complexes Following Adeno-Associated Virus (AAV) Transduction

Gary C. Pien, MD, PhD, Nicole C. Hasbrouck, MD, Marcela V. Maus, MD, PhD, Federico Mingozzi, PhD, Katherine A. High, MD

Blood (2007) 110 (11): 3737.

https://doi.org/10.1182/blood.V110.11.3737.3737

Published: 2007

Journal Articles

A Novel Splenocyte Approach for Characterizing T Cell Responses to Adeno-Associated Virus in the Normal Population: Implications on Gene Transfer.

Daniel J. Hui, PhD, Federico Mingozzi, PhD, Marcela V. Maus, MD, PhD, Michael A. Tigges, PhD, Glenn F. Pierce, MD, PhD, Katherine A. High, MD

Blood (2006) 108 (11): 3258.

https://doi.org/10.1182/blood.V108.11.3258.3258

Published: 2006

Journal Articles

AAV-2 Capsid-Specific CD8+ T Cells Limit the Duration of Gene Therapy in Humans and Cross-React with AAV-8 Capsid.

Federico Mingozzi, PhD, Marcela V. Maus, MD,PhD, Denise E. Sabatino, PhD, Daniel J. Hui, PhD, John E.J. Rasko, MBBS, PhD, Margaret V. Ragni, MD, Catherine Scott Manno, MD, Hildegund C.J. Ertl, MD, Katherine A. High, MD

Blood (2006) 108 (11): 455.

https://doi.org/10.1182/blood.V108.11.455.455

Published: 2006

NARROW

Phase 1 Study of CART-Ddbcma, a CAR-T Therapy Utilizing a Novel Synthetic Binding Domain for the Treatment of Subjects with Relapsed and Refractory Multiple Myeloma

Idecabtagene Vicleucel (ide-cel, bb2121), a BCMA-Directed CAR T Cell Therapy, in Patients with Relapsed and Refractory Multiple Myeloma: Updated Results from Phase 1 CRB-401 Study

Use of CD70 Targeted Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Acute Myeloid Leukemia (AML)

Application of a Standardized Flow Cytometry Panel for Defining and Monitoring the Immunophenotype of CAR-T Cells

Exploiting the Zinc Finger Degrome Targeted By Lenalidomide to Engineer Reversible Off-Switch Degradable Chimeric Antigen Receptors

Engineering an Optimized Trimeric APRIL-Based CAR to Broaden Targetability of Multiple Myeloma

Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics

Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity

Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Expression of B Cell Maturation Antigen (BCMA) and Transmembrane Activator and Caml Interactor (TACI) Are Correlated and Can be Targeted at Multiple Points during the Course of Multiple Myeloma

Durable Clinical Responses in Heavily Pretreated Patients with Relapsed/Refractory Multiple Myeloma: Updated Results from a Multicenter Study of bb2121 Anti-Bcma CAR T Cell Therapy

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CTL019) in Conjunction with Salvage Autologous Stem Cell Transplantation for Advanced Multiple Myeloma

A Novel Phase-Change Hydrogel Substrate for T Cell Activation Promotes Increased Expansion of CD8+ Cells Expressing Central Memory and Naive Phenotype Markers

Artificial Antigen Presenting Cells Expand NY-ESO-1 Antigen-Specific CD8+ T Cells From Patients with Melanoma

Quantifying Capsid Peptide:MHC I Complexes Following Adeno-Associated Virus (AAV) Transduction

A Novel Splenocyte Approach for Characterizing T Cell Responses to Adeno-Associated Virus in the Normal Population: Implications on Gene Transfer.

AAV-2 Capsid-Specific CD8+ T Cells Limit the Duration of Gene Therapy in Humans and Cross-React with AAV-8 Capsid.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only